+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transseptal Access Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 275 Pages
  • July 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5918283
The global Transseptal Access Systems Market is set to experience substantial expansion over the next decade. According to a recent industry analysis by the publisher, the market is projected to grow from USD 1.16 billion in 2025 to USD 1.99 billion by the end of 2032, reflecting a robust CAGR of 8.02%. Increasing prevalence of atrial fibrillation, rising geriatric population, and advancements in catheter-based cardiac procedures are among the key factors propelling market momentum.

Market Insights

Transseptal access systems are essential for gaining safe and effective access to the left atrium during complex cardiac procedures, including atrial fibrillation ablation, mitral valve repair, and left atrial appendage (LAA) occlusion. With growing demand for minimally invasive cardiac surgeries and catheter-based interventions, the use of transseptal access devices such as sheaths and needles has surged globally.

Technological improvements, particularly the development of bi-directional steerable introducer sheaths, have significantly enhanced procedural accuracy and efficiency, making these systems more appealing to hospitals and cardiac specialists worldwide. Furthermore, the market has seen notable consolidation and innovation, as leading companies introduce integrated transseptal access solutions tailored to modern electrophysiology procedures.

Key Market Drivers

The primary factors driving growth in the transseptal access systems market include:

  • Increasing Atrial Fibrillation Cases: Atrial fibrillation is one of the most common arrhythmias, with prevalence rates escalating across both developed and developing nations. This trend is boosting demand for effective and minimally invasive treatment modalities.
  • Ageing Global Population: The rising number of elderly individuals susceptible to cardiovascular conditions is positively influencing the adoption of transseptal access systems in hospitals and specialized cardiac centers.
  • Technological Advancements: The development of advanced steerable sheaths and integrated access systems has improved procedural outcomes, encouraging adoption across electrophysiology labs.
  • Government and Insurance Support: Favorable healthcare policies and increased insurance coverage for cardiac procedures are supporting patient access to modern therapeutic technologies.

Business Opportunity

Emerging markets across Asia-Pacific and Latin America present lucrative opportunities for expansion, particularly where healthcare infrastructure is improving, and access to specialty cardiac care is expanding. Manufacturers are actively investing in regional partnerships and product localization to meet growing demand.

Product innovation remains a key focus, with leading players expanding their portfolios through strategic acquisitions and the launch of novel, integrated systems. Collaborations with local distributors and healthcare providers are helping global players penetrate previously untapped regions and reach new patient populations.

Regional Analysis

  • United States: The U.S. continues to dominate the global market, driven by high healthcare spending, widespread awareness, and the growing geriatric population. Supportive reimbursement policies and advanced hospital infrastructure also contribute to strong market performance.
  • Germany: In Europe, Germany represents a significant market due to its structured reimbursement models and increasing volume of catheter-based cardiac procedures. The country has been at the forefront of transseptal technology adoption.
  • China: China is projected to witness the fastest growth, fueled by rapid advancements in local medical technologies and increased partnerships with global medical device firms. Government investments in cardiovascular health and rising patient awareness are also pivotal growth contributors.

Key Players

The competitive Analysis includes global leaders and specialized manufacturers that are shaping the future of the market through innovation and strategic collaborations. Notable companies operating in the transseptal access systems market include:
  • Boston Scientific Corporation
  • Medtronic plc
  • Biosense Webster, Inc. (Johnson & Johnson)
  • Terumo Corporation
  • St. Jude Medical LLC (Abbott Laboratories)
  • Merit Medical Systems, Inc.
  • Baylis Medical Company, Inc.
  • Pressure Product Medical Device Manufacturing LLC
  • Cook Medical LLC
  • Transseptal Solutions, Inc.
  • Abbott Laboratories
  • Others
These companies are focusing on product enhancements, regional expansions, and mergers & acquisitions to gain a competitive edge.

Market Segmentation

By Product:

  • Transseptal Access Needle
  • Transseptal Access Sheath

By Application:

  • Atrial Fibrillation Ablation
  • Mitral Valve Repair
  • Left Atrial Appendage Occlusion

By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialty Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Oceania
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Transseptal Access Systems Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Transseptal Access Systems Market Outlook, 2019-2032
3.1. Global Transseptal Access Systems Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Transseptal Access Needle
3.1.1.2. Transseptal Access Sheath
3.2. Global Transseptal Access Systems Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Atrial Fibrillation Ablation
3.2.1.2. Mitral Valve Repair
3.2.1.3. Left Atrial Appendage Occlusion
3.3. Global Transseptal Access Systems Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Ambulatory Surgical Centres
3.3.1.3. Specialty Clinics
3.4. Global Transseptal Access Systems Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Transseptal Access Systems Market Outlook, 2019-2032
4.1. North America Transseptal Access Systems Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Transseptal Access Needle
4.1.1.2. Transseptal Access Sheath
4.2. North America Transseptal Access Systems Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Atrial Fibrillation Ablation
4.2.1.2. Mitral Valve Repair
4.2.1.3. Left Atrial Appendage Occlusion
4.3. North America Transseptal Access Systems Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Ambulatory Surgical Centres
4.3.1.3. Specialty Clinics
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Transseptal Access Systems Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
4.4.1.2. U.S. Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
4.4.1.3. U.S. Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
4.4.1.4. Canada Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
4.4.1.5. Canada Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
4.4.1.6. Canada Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Transseptal Access Systems Market Outlook, 2019-2032
5.1. Europe Transseptal Access Systems Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Transseptal Access Needle
5.1.1.2. Transseptal Access Sheath
5.2. Europe Transseptal Access Systems Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Atrial Fibrillation Ablation
5.2.1.2. Mitral Valve Repair
5.2.1.3. Left Atrial Appendage Occlusion
5.3. Europe Transseptal Access Systems Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centres
5.3.1.3. Specialty Clinics
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Transseptal Access Systems Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.2. Germany Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.3. Germany Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.4. U.K. Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.5. U.K. Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.6. U.K. Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.7. France Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.8. France Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.9. France Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.10. Italy Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.11. Italy Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.12. Italy Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.13. Turkey Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.14. Turkey Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.15. Turkey Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.16. Russia Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.17. Russia Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.18. Russia Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.19. Rest of Europe Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.20. Rest of Europe Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1.21. Rest of Europe Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Transseptal Access Systems Market Outlook, 2019-2032
6.1. Asia Pacific Transseptal Access Systems Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Transseptal Access Needle
6.1.1.2. Transseptal Access Sheath
6.2. Asia Pacific Transseptal Access Systems Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Atrial Fibrillation Ablation
6.2.1.2. Mitral Valve Repair
6.2.1.3. Left Atrial Appendage Occlusion
6.3. Asia Pacific Transseptal Access Systems Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centres
6.3.1.3. Specialty Clinics
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Transseptal Access Systems Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.2. China Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.3. China Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.4. Japan Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.5. Japan Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.6. Japan Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.7. South Korea Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.8. South Korea Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.9. South Korea Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.10. India Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.11. India Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.12. India Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.13. Southeast Asia Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.14. Southeast Asia Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.15. Southeast Asia Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.16. Rest of Asia Pacific Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.17. Rest of Asia Pacific Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.18. Rest of Asia Pacific Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Transseptal Access Systems Market Outlook, 2019-2032
7.1. Latin America Transseptal Access Systems Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Transseptal Access Needle
7.1.1.2. Transseptal Access Sheath
7.2. Latin America Transseptal Access Systems Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019-2032
7.2.1.1. Atrial Fibrillation Ablation
7.2.1.2. Mitral Valve Repair
7.2.1.3. Left Atrial Appendage Occlusion
7.3. Latin America Transseptal Access Systems Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centres
7.3.1.3. Specialty Clinics
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Transseptal Access Systems Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.2. Brazil Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.3. Brazil Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.4. Mexico Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.5. Mexico Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.6. Mexico Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.7. Argentina Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.8. Argentina Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.9. Argentina Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.10. Rest of Latin America Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.11. Rest of Latin America Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.12. Rest of Latin America Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Transseptal Access Systems Market Outlook, 2019-2032
8.1. Middle East & Africa Transseptal Access Systems Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Transseptal Access Needle
8.1.1.2. Transseptal Access Sheath
8.2. Middle East & Africa Transseptal Access Systems Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Atrial Fibrillation Ablation
8.2.1.2. Mitral Valve Repair
8.2.1.3. Left Atrial Appendage Occlusion
8.3. Middle East & Africa Transseptal Access Systems Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centres
8.3.1.3. Specialty Clinics
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Transseptal Access Systems Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.2. GCC Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.3. GCC Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.4. South Africa Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.5. South Africa Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.6. South Africa Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.7. Egypt Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.8. Egypt Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.9. Egypt Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.10. Nigeria Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.11. Nigeria Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.12. Nigeria Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.13. Rest of Middle East & Africa Transseptal Access Systems Market by Product, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.14. Rest of Middle East & Africa Transseptal Access Systems Market by Application, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.15. Rest of Middle East & Africa Transseptal Access Systems Market by End User, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Segment 3 vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Boston Scientific Corporation
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Medtronic plc
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Biosense Webster, Inc. (Johnson & Johnson)
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Terumo Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. St. Jude Medical LLC (Abbott Laboratories)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Merit Medical Systems, Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Baylis Medical Company, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Pressure Product Medical Device Manufacturing LLC
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Cook Medical LLC
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Transseptal Solutions, Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Abbott Laboratories
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Boston Scientific Corporation
  • Medtronic plc
  • Biosense Webster, Inc. (Johnson & Johnson)
  • Terumo Corporation
  • St. Jude Medical LLC (Abbott Laboratories)
  • Merit Medical Systems, Inc.
  • Baylis Medical Company, Inc.
  • Pressure Product Medical Device Manufacturing LLC
  • Cook Medical LLC
  • Transseptal Solutions, Inc.
  • Abbott Laboratories